Basics XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. IPO Date: July 1, 1986 Sector: Healthcare Industry: Biotech Market Cap: $298.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.14% Avg Daily Range (30 D): $0.52 | 2.15% Avg Daily Range (90 D): $0.48 | 2.08% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 405 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 376 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $10.64M Avg Inst. Trade (90 D): $13.81M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.89M Avg Closing Trade (30 D): $1.46M Avg Closing Trade (90 D): $1.46M Avg Closing Volume: 81.08K         News May 27, 2025 @ 12:01 PM XOMA Royalty Purchases Mezagitamab Royalty and Mil... Source: Globe Newswire Mar 20, 2025 @ 11:30 AM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire Dec 19, 2024 @ 12:30 PM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Jul 9, 2024 @ 3:12 PM XOMA Corp to rebrand as XOMA Royalty Corporation B... Source: Ismeta Mujdragic Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.1 $.06 $-.45 Diluted EPS $-1.14 $.06 $-.45 Revenue $ 42.91M $ 15.91M $ 8.71M Gross Profit $ $ $ Net Income / Loss $ -2.86M $ 2.37M $ -3.97M Operating Income / Loss $ -27.04M $ 5.93M $ -7.25M Cost of Revenue $ $ $ Net Cash Flow $ -47.37M $ -11.39M $ -40.4M PE Ratio     Splits Oct 18, 2016:   1:20 Aug 18, 2010:   1:15